Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis | ANNALS OF ONCOLOGY |